Deep Dissecting Hematoma Requiring Surgical Removal During Veno-Venous Extracorporeal Membrane Oxygenation Management: A Case ReportPlastic Surgery Published on 2024-08-012024-09-05 Journal: Cureus [Category] update2024, [키워드] anticoagulant therapy COVID-19 deep dissecting hematoma dermatoporosis Steroids VV-ECMO [DOI] 10.7759/cureus.65976 PMC 바로가기 [Article Type] Plastic Surgery
COVID-19 and Peripheral Artery Thrombosis: A Mini ReviewReview article Published on 2022-10-012022-10-05 Journal: Current problems in cardiology [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] acute respiratory distress addition anticoagulant therapy Artery complex coronavirus coronavirus disease COVID-19 COVID-19 patients diagnostic disease Effect effective Health care system Hemostasis immune system management Manifestations MINI morbidity Mortality pandemic pathophysiology Patient patients patients with COVID-19 peripheral reported reveal review syndrome Thrombectomy Thromboembolism Thromboprophylaxis thrombosis thrombotic event Treatment venous while [DOI] 10.1016/j.cpcardiol.2021.100992 [Article Type] Review article
Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forumCOVID-19 대유행 중 혈전색전증 예방 및 항응고 요법: 항응고 포럼에서 업데이트된 임상 지침Article Published on 2022-08-012022-09-12 Journal: Journal of Thrombosis and Thrombolysis [Category] MERS, 진단, [키워드] anticoagulant therapy anticoagulation approach Aspirin clinical evidence clinical trial condition Consensus COVID-19 COVID-19 infection COVID-19 pandemic COVID-19 vaccination Direct Direct oral anticoagulant Direct-acting oral anticoagulant enoxaparin Evidence Forum Guidance hospitalized patients In-hospital Low-molecular-weight heparin North observational study Patient patients hospitalized patients with COVID-19 Pregnancy Prophylactic Prophylaxis provide provided rivaroxaban. stewardship Thrombophilia Thromboprophylaxis Thrombosis and thrombocytopenia syndrome thrombotic Venous Thromboembolism [DOI] 10.1007/s11239-022-02643-3 PMC 바로가기 [Article Type] Article
Imaging features and ultraearly hematoma growth in intracerebral hemorrhage associated with COVID-19COVID-19와 관련된 뇌내 출혈의 영상 특징 및 초초기 혈종 성장Multicenter Study Published on 2022-07-012022-09-11 Journal: Neuroradiology [Category] MERS, 바이오마커, [키워드] Analysis analyzed anticoagulant therapy Anticoagulant treatment antiplatelet antithrombotic therapy association baseline bleeding Case-control Characteristics characterized clinical Computed tomography confounding factor confounding factors Control COVID-19 COVID-19 disease COVID-19 patient defined demographic demographic characteristics disease exclusion feature growth hematoma hemorrhage heterogeneous hypodensity ICH imaging Intracerebral hemorrhage Laboratory Linear regression marker mechanisms median multicenter multifocal multivariable outcome Patient patients with COVID-19 predictor remained Research retrospective risk factor SARS-CoV-2 severity of COVID-19 significantly higher significantly more stroke Systolic blood pressure two groups Vascular Volume were recorded with COVID-19 [DOI] 10.1007/s00234-021-02861-1 PMC 바로가기 [Article Type] Multicenter Study
Splenic infarct in a COVID-19 patient under anticoagulant therapy with normal D-dimer levelsCase report Published on 2022-03-012022-10-05 Journal: International Journal of Surgery Case Reports [Category] 유전자 메커니즘, 치료제, [키워드] abdominal pain Acute myocardial infarction Anticoagulant anticoagulant therapy Anticoagulant treatment chest pain Coagulopathy Computerized tomography COVID-19 COVID-19 patient D-dimer level described discharged drug dose ECG Follow-up Hospitalization hospitalized COVID-19 patient laboratory parameter Leukocytosis LMWH multisystemic Myocardial nine Patient patients PCR positivity Pneumonia presenting Prevent problem prophylactic dose Prophylaxis receiving Seven shown Splenic Splenic infarction Thromboembolism thrombosis Thrombotic events Treatment was increased was performed [DOI] 10.1016/j.ijscr.2022.106847 [Article Type] Case report
A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications긴 코비드/PASC에서 아밀로이드 피브린 마이크로 클로트의 중심 역할 : 기원 및 치료 적 영향Review Published on 2022-02-252022-09-10 Journal: Biochemical Journal [Category] COVID19(2023년), Fulltext, MERS, SARS, 치료기술, 치료제, [키워드] acute COVID-19 amyloid anticoagulant therapy autoantibodies Blood Blood coagulation breathlessness Capillaries chronic fatigue syndrome clotting Coagulation Coagulopathies Coagulopathy COVID COVID-19 demographics disease entity disorders Encephalomyelitis fatigue fatigue syndrome FIBRIN fibrinogen fibrinolysis fluorescence microscope Health implication individual Infection Inflammation initial lead leads limit Long majority manifested Microscope PASC passage phenotype plasma Platelet platelet-poor plasma preliminary report Proteins proteolysis recognize red blood cell red blood cells referred to Regulatory removal SARS-COV-2 infection shown similarities similarity stain Symptom Symptoms syndrome terminology therapeutic these symptoms Thioflavin tissue damage Treatment [DOI] 10.1042/BCJ20220016 PMC 바로가기 [Article Type] Review
Anticoagulant therapy for COVID-19: What we have learned and what are the unanswered questions?Editorial Published on 2022-02-012023-07-07 Journal: European journal of internal medicine [Category] COVID19(2023년), [키워드] anticoagulant therapy COVID-19 thrombosis [DOI] 10.1016/j.ejim.2021.11.003 PMC 바로가기 [Article Type] Editorial
Coagulation System Activation for Targeting of COVID-19: Insights into Anticoagulants, Vaccine-Loaded Nanoparticles, and Hypercoagulability in COVID-19 VaccinesReview Published on 2022-01-242022-10-28 Journal: Viruses [Category] COVID-19, [키워드] Activation acute respiratory syndrome addition Anticoagulant anticoagulant agent anticoagulant therapy Anticoagulants Blood coagulation Coagulation system Coagulopathy Complication complications coronavirus COVID-19 COVID-19 vaccine COVID-19 vaccines cytokine Cytokine storm D-dimer Degradation drugs elevated help hypercoagulability immune Infection Inflammation insight life-threatening lower mortality mitigate Mortality Nanoparticles natural anticoagulants organ damage outbreak overlap Patient poor prognosis Prevalence Research responsible SARS-CoV-2 severe COVID-19 Side effect symptoms of COVID-19 syndrome System targeting thrombosis Treatment with COVID-19 worldwide pandemic [DOI] 10.3390/v14020228 PMC 바로가기 [Article Type] Review
Circulating Microparticles in the Pathogenesis and Early Anticoagulation of Thrombosis in COVID-19 With Kidney InjuryCell and Developmental Biology Published on 2022-01-182022-10-31 Journal: Frontiers in Cell and Developmental Biology [Category] COVID-19, [키워드] abnormality Activation Acute kidney injury affecting aggravate anticoagulant therapy anticoagulation Apoptosis binding site Blood blood cell blood circulation blood flow velocity can be used caused cells circulating clinical manifestations clinical outcomes clinical study Coagulation coagulation cascade Coagulopathy complexes consequence COVID-19 COVID-19 infection cytokine damaged cells dead Diseases early anticoagulation endothelial injury hospital hypercoagulability Immune cell impaired function IMPROVE inflammatory factors Injury kidney Kidney injury mechanism membrane Microparticle Mortality oxygen pandemic pathophysiological mechanism Patient Perspective Phosphatidylserine platform predict progression Prophylactic provide reduce rehabilitation released renal resulting risk factor thrombosis Treatment Vascular vascular endothelial cells viruses [DOI] 10.3389/fcell.2021.784505 PMC 바로가기 [Article Type] Cell and Developmental Biology
Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical TrialCOVID-19로 입원한 중환자 중 장기 지원 없이 생존에 대한 P2Y12 억제제의 효과: 무작위 임상 시험Randomized Controlled Trial Published on 2022-01-182022-09-25 Journal: JAMA [Category] 임상, 진단, 치료법, [키워드] 1:1 adaptive addition adjusted odds ratio age anticoagulant therapy assigned benefit bleeding Brazil clinical Clinical outcome conducted COVID-19 criterion defined dose Effect evaluate evaluated Final Follow-up Free hospital hospital discharge Hospitalization Hospitalized Ill In-hospital death inhibitor IQR Italy less Major major bleeding median non-critically ill patient occurred Odds ratio Open-label organ organ support outcome outcomes P2Y12 Patient patients with COVID-19 posterior probability potential therapeutic target Primary outcome Randomized randomized clinical trial risk Society Spain therapeutic those who survived ticagrelor Trial usual care usual care group was used women [DOI] 10.1001/jama.2021.23605 PMC 바로가기 [Article Type] Randomized Controlled Trial